8,485
Participants
Start Date
August 21, 2018
Primary Completion Date
March 15, 2023
Study Completion Date
February 2, 2024
DuraPrep
The iodine-based treatment intervention is an antiseptic solution comprised of iodine povacrylex (0.7% free iodine) in 74% isopropyl alcohol. 3M™ DuraPrep™ \[3M Health Care, St Paul, MN\], will be the commercial product used.
ChloraPrep
The CHG intervention is an antiseptic solution comprised of 2% CHG in 70% isopropyl alcohol. ChloraPrep® \[CareFusion Inc., Leawood, KS, USA\] will be the product used.
University of Pennsylvania, Philadelphia
University of Maryland Capital Region Health, Cheverly
University of Maryland, R Adams Cowley Shock Trauma Center, Baltimore
Inova Health System Foundation / Inova Fairfax Hospital, Falls Church
Wake Forest Baptist University Medical Center, Winston-Salem
Duke University Hospital, Durham
Carolinas Medical Center, Atrium Health Musculoskeletal Institute, Charlotte
Greenville Health System, Greenville
University of Mississippi Medical Center, Jackson
Case Western / MetroHealth Medical Center, Cleveland
University of Cincinnati Medical Center, Cincinnati
Indiana University Health Methodist Hospital, Indianapolis
University of Wisconsin, Madison
Sanford Health, Sioux Falls
Bryan Health, Lincoln
Louisiana State University, Baton Rouge
San Antonio Military Medical Center, San Antonio
University of Utah, Salt Lake City
Cedars Sinai, Los Angeles
University of California, Irvine, Irvine
Regional Medical Center of San Jose, San Jose
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Dartmouth-Hitchcock Medical Center, Hanover
Royal Columbia Hospital, New Westminster
Hamilton Health Sciences, Hamilton
McMaster University, Center for Evidence-Based Orthopaedics, Hamilton
McMaster University
OTHER
Patient-Centered Outcomes Research Institute
OTHER
University of Maryland, Baltimore
OTHER